EC
Insider
Eric Crombez
EVP and Chief Medical OfficerEric Crombez (EVP and Chief Medical Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Ultragenyx Pharmaceutical Inc. (RARE). The largest single filing was $160K of RARE (7,029 sh × $22.80, as filed), executed Mar 2.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$305K
shares × price, as filed
Last traded
May 15
Filed May 15
Median ADV $57.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $681K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
RARERecent filings
ABEOSALE
Abeona Therapeutics Inc.
View filing →
$145K26,143 sh × $5.53
Exec May 15
Filed May 15 · 5:30 PM ET RARESALE Ultragenyx Pharmaceutical Inc. View filing → $160K
7,029 sh × $22.80
Exec Mar 2
Filed Mar 3 · 5:30 PM ET RARESALE Ultragenyx Pharmaceutical Inc. View filing → $377K
8,945 sh × $42.10
Exec Mar 3 2025
Filed Mar 4 2025 · 5:30 PM ET